Carson City, Nevada, March 26, 2018, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN), (“Cell MedX” or the “Company”), an early-stage biotech company focusing on the discovery, development and commercialization of products that promote general wellness, is pleased to announce that it…
Carson City, Nevada, March 19, 2018, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN), (“Cell MedX” or the “Company”), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes has arranged a non-brokered…